Combination of Platelet-Rich Fibrin and Calcium Sulfate in Socket Augmentation

Sponsor
University of Malaya (Other)
Overall Status
Completed
CT.gov ID
NCT03851289
Collaborator
(none)
10
2
21.5

Study Details

Study Description

Brief Summary

This study evaluated the effectiveness of socket grafting material, combination of plate-rich fibrin and calcium sulfate. 5 subjects were grafted with this material, 5 subjects were grafted with combination of plate-rich fibrin and xenograft.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: platelet-rich fibrin and calcium sulfate
  • Combination Product: platelet-rich fibrin and xenograft
N/A

Detailed Description

Calcium sulfate (CS), an alloplastic material, is widely accepted as a socket grafting material and undergoes rapid and complete resorption. Studies have shown that CS creates an osteoconductive lattice that stimulates bone ingrowth into a defect. PRF poses multiple growth factors, anti-inflammatory cytokines and adhesion molecules. It is biologically active up to one week. The combination of these 2 materials will serve as good grafting material for tooth socket, in order to preserve vertical and horizontal dimensions.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Combination of Platelet-Rich Fibrin and Calcium Sulfate in Socket Augmentation
Actual Study Start Date :
Apr 22, 2016
Actual Primary Completion Date :
Jul 14, 2017
Actual Study Completion Date :
Feb 6, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: test (PRF-CS)

After atraumatic tooth extraction, the socket was gently curettage and irrigated with saline. Combination of platelet-rich fibrin and calcium sulfate was placed into the socket followed by a PRF plug . Black silk suture (3-0) was placed on mesial, mid and distal using simple interrupted technique.

Combination Product: platelet-rich fibrin and calcium sulfate

Active Comparator: control (PRF-X)

After atraumatic tooth extraction, the socket was gently curettage and irrigated with saline. Combination of platelet-rich fibrin and xenograft (MinerOss® X) was placed into the socket followed by a PRF plug . Black silk suture (3-0) was placed on mesial, mid and distal using simple interrupted technique.

Combination Product: platelet-rich fibrin and xenograft

Outcome Measures

Primary Outcome Measures

  1. vertical dimension at baseline [before extraction]

    measurements were done on radiograph (CBCT) images

  2. horizontal dimension at baseline [before extraction]

    measurements were done on radiograph (CBCT) images

  3. soft tissue level at baseline [before extraction]

    measurements were done on stone models

  4. volume at baseline [before extraction]

    measurements were done on radiograph (CBCT) images

Secondary Outcome Measures

  1. vertical dimension after extraction [five months after extraction]

    measurements were done on radiograph (CBCT) images

  2. horizontal dimension after extraction [five months after extraction]

    measurements were done on radiograph (CBCT) images

  3. soft tissue level after extraction [five months after extraction]

    measurements were done on stone models

  4. volume after extraction [five months after extraction]

    measurements were done on radiograph (CBCT) images

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • maxillary premolar teeth requiring extraction

  • neighboring mesial and distal sound/restored teeth present

  • alveolar bone level (measured from periapical radiographs) more than 50% of the root length

  • age ranges from 25-55 years

Exclusion Criteria:
  • bony fenestration of the socket wall confirmed from CBCT scan

  • acute signs of infection

  • periodontally compromised teeth

  • absence of buccal plates

  • any systemic disease which may hinder the healing process

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Malaya

Investigators

  • Principal Investigator: CHIA W CHEAH, University of Malaya

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Dr CHEAH CHIA WEI, Principal Investigator, University of Malaya
ClinicalTrials.gov Identifier:
NCT03851289
Other Study ID Numbers:
  • DF RD 1621/0076 (L)
First Posted:
Feb 22, 2019
Last Update Posted:
Mar 25, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr CHEAH CHIA WEI, Principal Investigator, University of Malaya
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2020